跳至主要内容
临床试验/IRCT20200328046886N5
IRCT20200328046886N5招募中2 期

Evaluation of Effect of N-acetylcysteine On Rate and Severity of Colistin Nephrotoxicity: A Randomized Double-blind Placebo-controlled Trial

Mazandaran University of Medical Sciences0 个研究点目标入组 48 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
招募中
入组人数
48

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Patients over 18 years old
  • Use of colistin for five days or longer as IV antimicrobial therapy in patients with nosocomial infections
  • Obtaining a written informed consent form from all patients or their guardians

排除标准

  • Receive NAC less than 24 hours before the first dose of colistin
  • Patients undergoing hemodialysis or peritoneal dialysis
  • Receiving contrast material for radiological imaging
  • Pregnant and lactating women
  • Known allergy to colistin or N-acetylcysteine (NAC)
  • Patient with recent history of cardiopulmonary resuscitation
  • Patients with systolic blood pressure <90 mmHg
  • GFR<60 ml/min

研究者

相似试验